Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Using credit card points for travel can transform your journeys. Explore our guide to make the most of your points for unforgettable trips.
19,769 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Mara Holdings and Riot Platforms fell Friday as higher energy costs collide with investors' questions about AI-driven...
U.S. prosecutors in New York investigate links between Colombia's president and drug traffickers, while the DEA desig...
Royal Caribbean enters 2026 with strong demand, but fuel cost headwinds and a heavy capex slate threaten margins, rem...
U.S. prosecutors allege a scheme to move Nvidia GPUs and servers to China, with Supermicro’s co-founders at the cente...
AI ambitions collide with power limits. This article explains the gigawatt pivot, why it matters for investors, and w...
Agentic AI is shifting how machines act on goals, not just how they think. This piece explains why Jensen Huang’s vie...
Bitcoin built on recent gains as macro risk appetite improved and liquidity returned, setting the stage for a test of...
Volatile markets test an investor’s nerves and resolve. The key to thriving, not just surviving, is focusing on a dis...
A new class of job-search firms charges up front fees to run an entire hunt for candidates. The market that reverse r...
In 2026, breadth returns as equal-weight ETFs beat the S&P 500, nudging investors toward diversified exposure. Here a...
A decade of dividend growth and a tiny fee have made the Vanguard Dividend Appreciation ETF a standout for risk-aware...